SSI Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

SSI Investment Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.09M	Sell	36,081 -23	-0.1%	-$3.93K	0.42%	83
2025 Q4	$6.09M	Buy	+36,104	New	+$5.86M	0.41%	80
2023 Q1	–	Sell	-21,577	Closed	-$2.83M	–	269
2022 Q4	$2.83M	Hold	21,577	–	–	0.18%	130
2022 Q3	$2.52M	Buy	+21,577	New	+$2.68M	0.17%	143
2017 Q1	–	Sell	-24,789	Closed	-$2.19M	–	307
2016 Q4	$2.19M	Hold	24,789	–	–	0.2%	163
2016 Q3	$2.39M	Buy	24,789 +441	+2%	+$42K	0.21%	156
2016 Q2	$2.09M	Buy	+24,348	New	+$2.18M	0.2%	154

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SSI Investment Management's IBB Position: Q1 2026 in Review

SSI Investment Management reduced its iShares Biotechnology ETF (IBB) stake by 0.06% in Q1 2026, selling an estimated $3.93K and leaving 36,081 shares worth $6.09M. The position accounts for 0.42% of the portfolio, ranked #83.

SSI Investment Management first reported a position in IBB in Q2 2016 and has held it in 7 quarters since. The position peaked at $6.09M in Q4 2025. 919 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

SSI Investment Management held 36,081 shares of iShares Biotechnology ETF worth $6.09M as of Q1 2026.
SSI Investment Management sold 23 iShares Biotechnology ETF shares in Q1 2026, an estimated $3.93K.
iShares Biotechnology ETF made up 0.42% of SSI Investment Management's portfolio in Q1 2026, its #83 holding.
SSI Investment Management first reported a position in iShares Biotechnology ETF in Q2 2016 and has held it in 7 quarters since.
SSI Investment Management's iShares Biotechnology ETF position peaked at $6.09M in Q4 2025.
919 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on SSI Investment Management's 13F filing for Q1 2026, filed 14 May 2026.